Please assess the completion status of the following clinical trial:

Trial Title: Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of ADHD (any sub-type) with oppositional defiant disorder.~* Clinical diagnosis of ADHD (any sub-type) with conduct disorder.~* Clinical diagnosis of other specified ADHD with oppositional defiant disorder.~* Clinical diagnosis of other specified ADHD with conduct disorder.~* Clinical diagnosis of unspecified ADHD with oppositional defiant disorder.~* Clinical diagnosis of unspecified ADHD with conduct disorder.~Exclusion Criteria:~* Participant who do not qualify for inclusion criteria.~* Participant who are not willing to join the study.~* Epilepsy.~* Neuro-genetic syndromes.~* Brain tumors.~* Autism.~* Participants who are under psychiatric medication and have changed it (dose or kind) in the last month.~* Congenital heart, kidney of liver defects.~* Cardiomyopathies.~* Past hypersensitivity to Methylphenidate or Risperidone.

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Methylphenidate (Type: ACTIVE_COMPARATOR): Participants in this arm will be given either Concerta - a long acting (12 hours) Methylphenidate pill - once daily, in the morning (starting dose 1 mg/kg, max dose 2 mg/kg), or Ritalin LA - a long acting (10 hours) Methylphenidate pill - once daily, in the morning (starting dose 0.6 mg/kg, max dose 1.5 mg/kg) for children who can not swallow pills.
- Risperidone (Type: ACTIVE_COMPARATOR): Participants in this arm will be given a low dose of Risperidone. Starting dose will be 0.5 mg/d, max dose will be 2 mg/d.

Based on this trial design, predict the completion outcome and termination type (if applicable).